LBTD — Lotus Bio-Technology Development Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for Lotus Bio-Technology Development, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	2013 March 31st	R2014 March 31st	2015 March 31st	R2016 March 31st	2017 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K/A
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-0.062	-0.016	-0.019	-0.019	-0.02
Amortisation
Non-Cash Items	0	—	—	0	0.005
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-0.01	0.004	0.003	0.02	-0.004
Change in Accounts Payable
Change in Payable / Accrued Expenses
Cash from Operating Activities	-0.072	-0.012	-0.016	0.002	-0.018
Capital Expenditures	0	—	—	—	—
Software Development Costs
Cash from Investing Activities	0	—	—	—	—
Financing Cash Flow Items	-0.028	0.008	0.017	0	0.011
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	0.076	0.008	0.017	0	0.018
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	0.004	-0.004	0.002	0.002	0